Min Aik Technology Co (3060) Fair Value & Analysis
Technology · TW · Market cap 4.3B TWD
Fair value as of: Jun 24, 2026
Analysis
Min Aik Technology Co (3060) currently trades at 38.60 TWD, while our model-based Fair Value estimate is 14.58 TWD — implying the stock looks roughly 62.2% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Min Aik Technology Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of hard drive components, precision electronic component assemblies, medical device components, optical components, and precision plastic molds. The company offers OEM/ODM products comprising automation equipment, pixel shifting actuator technology, consumer electronics, precision components and assembly, hard disk components, and medical devices. It also provides voice coil motor, hard disk upper cover, external storage device, spare parts for hard disk, microscope part, and other products. In addition, the company provides technical, measurement, and analysis services. It operates in Thailand, Singapore, the United States, Taiwan, and internationally. Min Aik Technology Co., Ltd. was incorporated in 1979 and is based in Taoyuan City, Taiwan.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Min Aik Technology Co (3060) undervalued?
What is the fair value of 3060?
What is the quality score of 3060?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.